UBS Reiterates Buy Rating on Omega Healthcare Investors (OHI)

May 20, 2026 9:43 AM

UBS analyst Michael Goldsmith reiterated a Buy rating and $54.00 price target on Omega Healthcare Investors (NYSE: OHI).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found